STEPHAN HAAQUIST: Open Payments
NPI 1194418202 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,109 in 35 payments from 8 companies in 2025. Trend: 2023 $14 · 2024 $544 · 2025 $1,109
Food & beverage: $1,109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 17 | $310 |
| Otsuka America Pharmaceutical, Inc. | 5 | $181 |
| Alkermes, Inc. | 5 | $176 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $99 |
| Janssen Pharmaceuticals, Inc | 3 | $55 |
| Neurocrine BioSciences, Inc. | 2 | $38 |
Products named: ARISTADA, UZEDY, AUSTEDO XR, REXULTI, Auvelity, FANAPT, CAPLYTA, INVEGA SUSTENNA.
Industry payments across NY — which companies pay providers there.
